ELAN Insider Trading

Insider Ownership Percentage: 0.89%
Insider Buying (Last 12 Months): $1,818,675.00
Insider Selling (Last 12 Months): $0.00

Elanco Animal Health Insider Trading History Chart

This chart shows the insider buying and selling history at Elanco Animal Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$1M-$500k$0$500k$1MTotal Insider BuyingTotal Insider Selling

Elanco Animal Health Share Price & Price History

Current Price: $9.75
Price Change: Price Increase of +0.275 (2.90%)
As of 05/2/2025 04:59 PM ET

This chart shows the closing price history over time for ELAN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
JunJulAugSepOctNovDecJanFebMarApr$9.74Closing price on 05/04/25:

SEC Filings (Institutional Ownership Changes) for Elanco Animal Health (NYSE:ELAN)

97.48% of Elanco Animal Health stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ELAN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$19Mbought$6.10MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$600M-$400M-$200M$0$200M$400M$600MTotal InflowsTotal Outflows
Elanco Animal Health logo
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
Read More on Elanco Animal Health

Today's Range

Now: $9.75
Low: $9.70
High: $9.91

50 Day Range

MA: $9.89
Low: $8.14
High: $11.33

52 Week Range

Now: $9.75
Low: $8.02
High: $18.80

Volume

3,509,607 shs

Average Volume

4,948,857 shs

Market Capitalization

$4.84 billion

P/E Ratio

24.36

Dividend Yield

N/A

Beta

1.49

Who are the company insiders with the largest holdings of Elanco Animal Health?

Elanco Animal Health's top insider shareholders include:
  1. R David Hoover (Director)
  2. Jeffrey N Simmons (CEO)
  3. Lawrence Erik Kurzius (Director)
  4. Michael J Harrington (Director)
  5. William F Doyle (Director)
Learn More about top insider investors at Elanco Animal Health.

Who are the major institutional investors of Elanco Animal Health?

Elanco Animal Health's top institutional shareholders include:
  1. Douglas Lane & Associates LLC — 0.78%
  2. Bank of New York Mellon Corp — 0.39%
  3. DDD Partners LLC — 0.30%
  4. Davidson Investment Advisors — 0.18%
  5. Harbor Capital Advisors Inc. — 0.18%
  6. Skylands Capital LLC — 0.11%
Learn More about top institutional investors of Elanco Animal Health stock.

Which major investors are selling Elanco Animal Health stock?

Within the previous quarter, ELAN stock was sold by these institutional investors:
  1. KBC Group NV
  2. Harbor Capital Advisors Inc.
  3. Nisa Investment Advisors LLC
  4. Bank of New York Mellon Corp
  5. Illinois Municipal Retirement Fund
  6. Teacher Retirement System of Texas
  7. Rhumbline Advisers
  8. Sapient Capital LLC

Which major investors are buying Elanco Animal Health stock?

During the previous quarter, ELAN stock was purchased by institutional investors including:
  1. DDD Partners LLC
  2. Douglas Lane & Associates LLC
  3. Victory Capital Management Inc.
  4. Country Club Bank
  5. SG Americas Securities LLC
  6. Sanders Morris Harris LLC
  7. IMC Chicago LLC
  8. Envestnet Asset Management Inc.
Within the last year, these company insiders have bought Elanco Animal Health stock:
  1. R David Hoover (Director)
  2. Jeffrey N Simmons (CEO)
  3. Lawrence Erik Kurzius (Director)
  4. Michael J Harrington (Director)
  5. William F Doyle (Director)
Learn More investors buying Elanco Animal Health stock.